Login
Menu
Home
(current)
Recurring Events
CE Calendar
Evaluations
Enduring Materials
Live Events
CE Applications
Links
Login
Enduring Material
Psound Bytes CME: Diagnosis and Treatment of Hard-To-Treat Psoriasis
View Activity Info
Enter Basic User Info
View Content
Take Post Test
Create Account
Done
View Activity Info
Continue to Enduring Material
6600 SW 92nd Ave., Suite 300
Portland, OR 97223-7195
General Information
Active Dates
Wednesday, July 7, 2021 - Friday, July 7, 2023
Estimated Completion Time
30 minutes
Conference Host
National Psoriasis Foundation
Conference Location
Virtual Conference Room
Conference Name
Psound Bytes CME Podcast
Provider
National Psoriasis Foundation
Watch this Lecture Remotely
Objectives
Event Objectives
Increased understanding of diagnosing and treating psoriasis affecting the eyes, ears and mouth
Presentations and Speakers
Presentation #1
Psound Bytes CME: Diagnosis and Treatment of Hard-To-Treat Psoriasis
Robert Kalb, MD
Available Credits/Points
Credit Designation
The National Psoriasis Foundation designates this enduring material for a maximum of 0.25
AMA PRA Category 1 Credits
. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The National Psoriasis Foundation designates this enduring material for a maximum of 0.25 Hour(s) Attendance w/ No Credit. Participants should claim only the credit commensurate with the extent of their participation in the activity.
Description
Diagnosing and treating uncommon areas affected by psoriasis can be challenging. Hear Dr. Robert Kalb, Clinical Professor, Dept of Dermatology at SUNY, Buffalo School of Medicine in Buffalo, NY, address such hard-to-treat areas as the eyes, ears and mouth. This program is supported by educational grants from Lilly, Bristol Myers Squibb, Novartis and Ortho Dermatologics.
Disclosure Statements
Series Disclosures
NPF Staff/Planning Committee, has disclosed no relevant financial relationships with commercial interests.
Event Disclosures
Speakers:
Robert Kalb, MD has disclosed a financial relationship with one or more ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
AbbVie - Contracted Research - Relationship Has Not Ended
Amgen - Consulting - Relationship Has Not Ended
Amgen, Galderma, Janssen-Ortho, Menlo Therapeutics, UCB - Contracted Research - Relationship Has Not Ended
Janssen-Ortho, Menlo Therapeutics, Sun Pharmaceutical, UCB - Consulting - Relationship Has Not Ended
Commercial Support
Support for this activity is gratefully acknowledged from BMS. Support for this activity is gratefully acknowledged from Eli Lilly & Company. Support for this activity is gratefully acknowledged from Novartis. Support for this activity is gratefully acknowledged from Ortho.
Accreditation Statement
The National Psoriasis Foundation is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Test Information
Percentage of Responses Required to Submit
100 %
Last Review Date
7/7/2021
Continue to Enduring Material
Powered By
eeds Privacy and Registration Refund Policy
|
eeds Accessibility Statement